AAN 2025: GLP-1 Analogues' Promise in Alzheimer Disease Treatment
April 7th 2025Glucagon-like peptide-1 (GLP-1) analogs demonstrate potential to address multiple pathological processes in Alzheimer disease, with promising early research suggesting cognitive improvements and potential for future treatment.
Watch
AAN 2025: Pharmacists Key Players in Safe, Effective Migraine Treatment With CGRP Antagonists
April 7th 2025Andrew Charles, MD, outlines why calcitonin-gene-related peptide (CGRP) antagonists are increasingly favored as first-line migraine treatments and how pharmacists play a key role in patient education and support.
Watch
AAN 2025: Specialty Pharmacists Improve Outcomes in Non-MS Clinics With High-Impact Interventions
April 6th 2025A study led by Kayla Johnson, PharmD, BCPS, BCPP found that integrating specialty pharmacists into non-multiple sclerosis (MS) neurology clinics led to significantly enhanced patient care and treatment outcomes.
Watch
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025Experts discuss Project Lifeline’s integration of SBIRT in community pharmacies, highlighting its effectiveness in identifying and addressing opioid use disorder while exploring strategies for broader implementation.
Listen
Marcella Kinaya, PharmD, on Flu Season: ‘We’re Here to Protect People and Make Sure They’re Healthy’
March 25th 2025A district leader at CVS Health emphasizes that patients should get tested, be up to date with immunizations, and staying home and reach out to health care professionals when experiencing symptoms.
Read More